The European Commission said on Wednesday it was in negotiations with Gilead Sciences Inc to obtain doses of COVID-19 antiviral remdesivir for the 27 European Union countries. The Commission said it took note of the announcement that the United States had secured nearly all of Gilead’s projected production capacity for the next three months.
from Yahoo Finance https://ift.tt/2Vw05PF
Leave a Reply